drugset / Trial / NCT06833788

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

NCT06833788

Phase 4 Recruiting 2860 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupOpen-labelHealth-services research

Summary

The objectif of the IRON-DEP Study is to assess the efficacy of intravenous (IV) versus oral iron treatment on the prevalence of postpartum depression (PPD) in women with moderate iron deficiency anemia after caesarean delivery.

Timeline

Start
2025-10-22
Primary completion
2028-06-22
Completion
2028-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Subject TIMOFÉROL® Unknown 100 mg Oral

Indications